Teladoc Health (NYSE:TDOC) Issues Quarterly Earnings Results

Teladoc Health (NYSE:TDOC) issued its quarterly earnings results on Thursday. The health services provider reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02), Briefing.com reports. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. During the same quarter in the previous year, the business posted ($0.37) EPS. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis.

Teladoc Health Stock Performance

Shares of NYSE:TDOC traded down $0.07 during midday trading on Friday, reaching $13.26. 3,582,607 shares of the company traded hands, compared to its average volume of 4,746,240. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. Teladoc Health has a 12 month low of $12.65 and a 12 month high of $30.41. The firm has a market capitalization of $2.25 billion, a price-to-earnings ratio of -9.87 and a beta of 0.94. The firm’s fifty day moving average price is $15.17 and its two-hundred day moving average price is $17.80.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on TDOC. SVB Leerink began coverage on Teladoc Health in a research note on Monday, February 26th. They set a “market perform” rating and a $17.00 price target on the stock. Canaccord Genuity Group cut their price target on Teladoc Health from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Friday. Citigroup cut their price objective on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. DA Davidson cut their price objective on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Nine equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $21.21.

Insider Activity at Teladoc Health

In other Teladoc Health news, CEO Jason N. Gorevic sold 53,755 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $780,522.60. Following the transaction, the chief executive officer now directly owns 653,073 shares in the company, valued at approximately $9,482,619.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Teladoc Health news, CEO Jason N. Gorevic sold 53,755 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $780,522.60. Following the transaction, the chief executive officer now directly owns 653,073 shares in the company, valued at approximately $9,482,619.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Stephany Verstraete sold 7,945 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $115,361.40. Following the completion of the transaction, the chief marketing officer now owns 56,486 shares in the company, valued at $820,176.72. The disclosure for this sale can be found here. In the last three months, insiders have sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.